Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
22 Feb 2022 |
On buy-back programmes |
ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.
|
Download |
|
16 Feb 2022 |
On business and financial situation |
Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years
|
Download |
|
03 Nov 2021 |
On buy-back programmes |
The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program.
|
Download |
|
16 Jul 2021 |
On Corporate Governance |
ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company
|
Download |
|
22 Jun 2021 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
02 Jul 2020 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the second quarter of 2020
|
Download |
|
13 May 2020 |
On business and financial situation |
ROVI releases the presentation related to the first quarter 2020 financial results
|
Download |
|
13 May 2020 |
Interim Management Report |
The company releases the press release related to the 2020 first quarter financial results
|
Download |
|
02 Apr 2020 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the first quarter of 2020
|
Download |
|
02 Apr 2020 |
On business and financial situation |
ROVI informs on the impact of Covid‑19 on the company’s activities
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Jul 2019 |
R&D: new licenses, patents and registered trademarks |
ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria® for the treatment of schizophrenia.
|
Download |
|
02 Jul 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the second quarter of 2019
|
Download |
|
26 Jun 2019 |
Información sobre dividendos |
The Company informs about the dividends payment
|
Download |
|
12 Jun 2019 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
08 May 2019 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI releases the information related to its 2019 General Shareholders Meeting
|
Download |
Pages
